Bibliography
Found 135 results
Filters: Author is Ellis, Ronald J [Clear All Filters]
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother. 2010 ;54(12):5156-60.
Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities. J Int Neuropsychol Soc. 2020 ;26(2):147-162.
The utility and limitations of the HIV Dementia Scale. In: Journal of the International Neuropsychological Society. Vol. 8. Journal of the International Neuropsychological Society. ; 2001. p. 160.
. Validation of post-mortem CSF viral load by comparison to ante-mortem viral load and clinical measurements. In: Journal of NeuroVirology. Vol. 9. Journal of NeuroVirology. ; 2003. p. 130.
. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008 ;65(1):65-70.
Value of neurocognitive status in predicting HIV-related brain disease. In: Journal of the International Neuropsychological Society. Vol. 7. Journal of the International Neuropsychological Society. ; 2001. p. 150.
. The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014 ;65(2):190-7.
. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis. 2016 ;63(5):694-702.
. White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol. 2019 ;25(1):32-41.
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009 ;15(2):187-95.